Skip to main content

Advertisement

Log in

The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The Revised Fibromyalgia Impact Questionnaire (FIQR) attempts to address the limitations of the Fibromyalgia Impact Questionnaire (FIQ). As there is no Turkish version of the FIQR available, we aimed to investigate the validity and reliability of a Turkish translation of the FIQR in Turkish female fibromyalgia (FM) patients. After translating the FIQR into Turkish, it was administered to 87 female patients with FM. All of the patients filled out the questionnaire together with a Turkish version of the FIQ, hospital anxiety and depression scales (HADS), short form-36 (SF-36). The tender-point count (TPC) was also calculated from tender points identified by thumb palpation. One week later, FM patients filled out the Turkish FIQR at their second visit. The test–retest reliability of the Turkish FIQR questions ranged from 0.714 to 0.898. The test and retest reliability of total FIQR score was 0.835. Cronbach's alpha was 0.89 for FIQR visit 1 (the first assessment) and 0.91 for FIQR visit 2 (the second assessment), indicating acceptable levels of internal consistency for both assessments. The total scores of the FIQR and FIQ were significantly correlated (r = 0.87, P < 0.01). Significant correlations for construct validity were also obtained between the FIQR total and domain scores and the FIQ, the HADS and the subscales of the SF-36 (FIQR total versus SF-36 physical component score and mental component score were r = −0.63, P < 0.01 and r = −0.51, P < 0.01, respectively). The Turkish FIQR is a reliable and valid instrument for measuring health status in FM, showing sufficient reliability and construct validity. It may be utilized for both clinical practice and research use in the Turkish-speaking population in place of FIQ, since its Turkish version has problems in the wording, omissions, concepts, and scoring from the original FIQ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. White K, Speechley M, Harth M, Ostbye T (1999) The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26:1570–1576

    PubMed  CAS  Google Scholar 

  2. Bennett RM, Jones J, Turk D, Russell IJ, Matallana L (2007) An internet survey of 2, 596 people with fibromyalgia. BMC Musculoskelet Disord 8:27

    Article  PubMed  Google Scholar 

  3. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam A, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon R (1990) The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172

    Article  PubMed  CAS  Google Scholar 

  4. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733

    PubMed  CAS  Google Scholar 

  5. Bernard AL, Prince A, Edsall P (2000) Quality of life issues for fibromyalgia patients. Arthritis Care Res 13:42–50

    Article  PubMed  CAS  Google Scholar 

  6. Offenbacher M, Cieza A, Brockow T, Amann E, Kollerits B, Stucki G (2007) Are the contents of treatment outcomes in fibromyalgia trials represented in the international classification of functioning, disability, and health? Clin J Pain 23:691–701

    Article  PubMed  Google Scholar 

  7. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL (2009) The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11:R120

    Article  PubMed  Google Scholar 

  8. Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20:9–12

    Article  PubMed  CAS  Google Scholar 

  9. Prodinger B, Cieza A, Williams DA, Mease P, Boonen A, Kerschan-Schindl K, Fialka-Moser V, Smolen J, Stucki G, Machold K, Stamm T (2008) Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the international classification of functioning, disability and health. Arthritis Rheum 59:650–658

    Article  PubMed  Google Scholar 

  10. Bennett R (2005) The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23:S154–S162

    PubMed  CAS  Google Scholar 

  11. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F (2008) Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 37:353–365

    Article  PubMed  CAS  Google Scholar 

  12. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Samsøe B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Späth M, Choy EH (2008) EULAR: EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536–541

    Article  PubMed  CAS  Google Scholar 

  13. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  14. Aydemir O (1997) Validity and reliability of Turkish version of hospital anxiety and depression scale (HADS). Hastane Anksiyete ve Depresyon Olceği (HADS) Turkce formunun gecerlilik ve guvenilirlik calışması. Türk Psikiyatri Derg 8:280–287

    Google Scholar 

  15. Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14:259–264

    Article  PubMed  Google Scholar 

  16. Salaffi F, Sarzi-Puttini P, Girolimetti R, Gasparini S, Atzeni F, Grassi W (2009) Development and validation of the self-administered fibromyalgia assessment status: a disease-specific composite measure for evaluating treatment effect. Arthritis Res Ther 11:R125

    Article  PubMed  Google Scholar 

  17. Salaffi F, Sarzi-Puttini P, Ciapetti A, Atzeni F (2009) Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 27:92–105

    Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Levent Ediz.

Appendix A. Turkish translation of the Revised Fibromyalgia İmpact Questionnaire (FIQR)

Appendix A. Turkish translation of the Revised Fibromyalgia İmpact Questionnaire (FIQR)

figure afigure a

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ediz, L., Hiz, O., Toprak, M. et al. The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire. Clin Rheumatol 30, 339–346 (2011). https://doi.org/10.1007/s10067-010-1546-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1546-8

Keywords

Navigation